(SCANS) Sickle Cell Anemia Neurodevelopmental Screening - Mentoring and Research in Patient Oriented Research
(扫描) 镰状细胞性贫血神经发育筛查 - 以患者为导向的研究的指导和研究
基本信息
- 批准号:10685968
- 负责人:
- 金额:$ 10.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAdherenceAdolescentAgeAmericanAmerican Society of HematologyAnemiaAwardAwarenessBiological FactorsCaringCerebral InfarctionChildChild DevelopmentChildhoodChronicClinicClinicalClinical InvestigatorCognitionCognitiveCognitive deficitsDevelopmentDevelopmental Delay DisordersDisciplineEarly InterventionEducationEvidence based interventionEvidence based practiceFacultyFamilyFundingFutureFuture GenerationsGeneral PractitionersGoalsGrantGuideline AdherenceGuidelinesHealth PersonnelHealth ProfessionalHematologistHematologyHemolytic AnemiaHomeHybridsImpaired cognitionImprisonmentIndividualInfantInfrastructureInheritedInterventionInterviewLanguage DevelopmentMedicalMedical StudentsMedicineMentorsMethodsOccupational TherapistOccupational TherapyOutcomeOxygenPatientsPediatric HematologyPediatricsPilot ProjectsPopulationPovertyPreventivePreventive carePrimary CarePrincipal InvestigatorProbabilityProviderPsychologistPsychologyPublic HealthRecommendationResearchResourcesRisk FactorsScanningSchoolsScientistSickle Cell AnemiaSleep Apnea SyndromesSpecialistStructureSurveysSystemTimeToddlerTrainingUnderrepresented MinorityUnemploymentVisitVulnerable Populationscareerclinically significantcognitive testingdisabilityearly childhoodearly screeningevidence baseexperiencehigh riskimplementation researchimplementation scienceimplementation strategyimprovedimproved outcomeinnovationinterestlow socioeconomic statuspatient oriented researchpractice-based research networkprimary care providerrecruitremediationscale upscreeningskillssocialstudent mentoringsuccesstraining opportunity
项目摘要
Sickle cell disease (SCD) is an inherited hemolytic anemia associated with under-recognized
developmental delay and cognitive deficits. Chronic anemia, low oxygen saturations, sleep-
disordered breathing, cerebral infarcts, and low socioeconomic status are risk factors for
clinically significant cognitive impairments. However, SCD can be an invisible disability.
Patients’ development is not routinely screened and deficits may remain undiagnosed. Early
childhood is the most important time to screen for delays because children can receive
evidence-based and federally mandated resources to remediate development before entering
school. Without such resources, this vulnerable population has a high probability of poor
academic attainment, unemployment, and incarceration. The long-term goal of the current
project is to prepare young children with SCD for early childhood education and sustained
academic success. To achieve this, Dr. King proposes to study the implementation of
developmental screening of young children with SCD, a typically overlooked population. Dr.
King is the principal investigator of a U01 grant in the Sickle Cell Disease Implementation
Consortium to provide cognitive screening and intervention for adolescents with SCD. She leads
a team of hematologists, a neuropsychologist, a social psychologist, occupational therapists,
and implementation scientists to both conduct interventions and study the implementation
science outcomes in order to “scale up” evidence-based practices. She will use this established
infrastructure to complete the following aims: Aim 1. To determine the barriers and facilitators of
surveillance and screening of early childhood development of children with SCD age 0-3 years,
and Aim 2. To identify specific implementation strategies to address the barriers and facilitators
to early childhood development screening. The results will inform the appropriate intervention to
improve developmental screening in children with SCD. This proposal will enhance Dr. King’s
career by allowing her to gain the necessary skills to recruit, educate, and mentor a cadre of
health professionals focused on implementation science for improving clinical and educational
outcomes in SCD. Dr. King has a long track record of mentoring students, trainees, and junior
faculty from multiple scientific disciplines including medicine, public health, psychology,
education, and occupational therapy. She has a particular interest in mentoring
underrepresented minorities, and she will continue to do so to develop future leaders.
镰状细胞病(SCD)是一种遗传性溶血性贫血,
发育迟缓和认知缺陷。慢性贫血、低氧饱和度、睡眠-
呼吸紊乱、脑梗死和社会经济地位低下是
有临床意义的认知障碍然而,SCD可能是一种无形的残疾。
患者的发展没有进行常规筛查,缺陷可能无法诊断。早期
儿童时期是筛查延迟的最重要时间,因为儿童可以接受
以证据为基础的和联邦授权的资源,以补救发展之前,进入
学校如果没有这些资源,这一弱势群体很有可能陷入贫困。
学历,失业和监禁。当前的长期目标
该项目旨在帮助患有SCD的幼儿接受早期教育,
学术上的成功为此,金博士建议研究实施
患有SCD的幼儿的发育筛查,这是一个通常被忽视的人群。博士
King是镰状细胞病实施项目U 01资助的首席研究员。
为患有SCD的青少年提供认知筛查和干预的联盟。她领导
一组血液学家,一个神经心理学家,一个社会心理学家,职业治疗师,
和实施科学家进行干预和研究的实施
科学成果,以“扩大”循证实践。她将利用这一既定的
基础设施,以完成以下目标:目标1。为了确定障碍和促进因素,
监测和筛查0-3岁SCD儿童的早期儿童发育,
目标2确定具体的实施战略,以解决障碍和促进因素
儿童早期发育筛查。结果将为适当的干预提供信息,
改善SCD儿童发育筛查。这项提案将加强金博士的
职业生涯,让她获得必要的技能,招聘,教育,并指导干部,
卫生专业人员专注于实施科学,以改善临床和教育
SCD的结果。金博士在指导学生、学员和初级学员方面有着悠久的历史。
教师来自多个科学学科,包括医学,公共卫生,心理学,
教育和职业治疗。她对指导特别感兴趣
她将继续这样做,以培养未来的领导人。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.
- DOI:10.1097/mph.0000000000002091
- 发表时间:2021-04-01
- 期刊:
- 影响因子:0
- 作者:Knight LMJ;King AA;Strouse JJ;Tanabe P
- 通讯作者:Tanabe P
Preferences for Participation Measurement Among Individuals Diagnosed With Cancer: A Qualitative Content Analysis.
癌症诊断个体的参与测量偏好:定性内容分析。
- DOI:10.1177/15394492231181104
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:L'Hotta,AllisonJ;Varughese,TaniyaE;Lyons,KathleenD;Trebelhorn,Audrey;Manohar,Annamayil;King,AllisonA
- 通讯作者:King,AllisonA
Trajectories of participation in daily life among individuals newly diagnosed with cancer: A 5-month longitudinal study.
- DOI:10.1007/s00520-023-07672-z
- 发表时间:2023-03-14
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review.
癌症儿童康复的临床实践指南和专家共识建议:系统评价。
- DOI:10.3322/caac.21783
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:L'Hotta,AllisonJ;Randolph,SamanthaB;Reader,Ben;Lipsey,Kim;King,AllisonA
- 通讯作者:King,AllisonA
Multimodal Ambulatory Monitoring of Daily Activity and Health-Related Symptoms in Community-Dwelling Survivors of Stroke: Feasibility, Acceptability, and Validity.
居住在社区居民中风幸存者日常活动和健康相关症状的多模式卧床监测:可行性,可接受性和有效性。
- DOI:10.1016/j.apmr.2022.06.002
- 发表时间:2022-10
- 期刊:
- 影响因子:4.3
- 作者:Lau, Stephen C. L.;Connor, Lisa Tabor;King, Allison A.;Baum, Carolyn M.
- 通讯作者:Baum, Carolyn M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allison A King其他文献
Emergency Admissions and the Prescribing of Buprenorphine, Methadone, and Psychotropic Medications in People with Sickle Cell Disease: An Analysis of National Insurance Claims
- DOI:
10.1182/blood-2023-173552 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Shiyuan Anabeth Liu;Tashalee R Brown;Lewei Allison Lin;Allison A King;Sana Saif Ur Rehman;Richard A Grucza;Kevin Y Xu - 通讯作者:
Kevin Y Xu
Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts
在镰状细胞病和无症状脑梗塞儿童的临床试验中,输血疗法是可行的
- DOI:
10.1002/pbc.21338 - 发表时间:
2008 - 期刊:
- 影响因子:3.2
- 作者:
Allison A King;M. Noetzel;D. White;R. McKinstry;M. Debaun - 通讯作者:
M. Debaun
Is There a Genetic Basis to Stroke in Children with Sickle Cell Disease?† 773
镰状细胞病患儿中风是否存在遗传基础?† 773
- DOI:
10.1203/00006450-199804001-00794 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Allison A King;Linda Resar;Eliot Vichinsky;Charles Pegelow;J Paul Scott;Michael R DeBaun - 通讯作者:
Michael R DeBaun
Eye‐related quality of life and activities of daily living in pediatric retinoblastoma patients: A single‐center, non‐controlled, cross‐sectional analysis
儿童视网膜母细胞瘤患者眼部相关生活质量和日常生活活动:单中心、非对照、横断面分析
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:3.2
- 作者:
Jacob Wise;R. Hayashi;Tiffany J Wu;S. Malone;Amer Al Badawi;Allison A King;Mae Gordon;Lawrencia Kimera;G. Lueder;Margaret M. Reynolds - 通讯作者:
Margaret M. Reynolds
Engagement with Incharge App - a Mobile Health Intervention to Improve Adherence to Hydroxyurea Among Individuals with Sickle Cell Disease
- DOI:
10.1182/blood-2023-179272 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Christina M Abrams;Natalia Davila;Cathy Melvin;Sherif M. Badawy;Michael B Potter;Robert Gibson;Allison A King;Victor R. Gordeuk;Chinonyelum Nwosu;Jerlym S. Porter;Sophie Li;Jeffrey A. Glassberg;Richard Lottenberg;Lisa Klesges;Nirmish Shah;Jane S Hankins - 通讯作者:
Jane S Hankins
Allison A King的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allison A King', 18)}}的其他基金
(SCANS) Sickle Cell Anemia Neurodevelopmental Screening - Mentoring and Research in Patient Oriented Research
(扫描) 镰状细胞性贫血神经发育筛查 - 以患者为导向的研究的指导和研究
- 批准号:
10219829 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
(SCANS) Sickle Cell Anemia Neurodevelopmental Screening - Mentoring and Research in Patient Oriented Research
(扫描) 镰状细胞性贫血神经发育筛查 - 以患者为导向的研究的指导和研究
- 批准号:
9804958 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
(SCANS) Sickle Cell Anemia Neurodevelopmental Screening - Mentoring and Research in Patient Oriented Research
(扫描) 镰状细胞性贫血神经发育筛查 - 以患者为导向的研究的指导和研究
- 批准号:
10021702 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
(SCANS) Sickle Cell Anemia Neurodevelopmental Screening - Mentoring and Research in Patient Oriented Research
(扫描) 镰状细胞性贫血神经发育筛查 - 以患者为导向的研究的指导和研究
- 批准号:
10455649 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and Back
实施认知筛查和教育支持以改善镰状细胞病青少年和年轻人的预后:从诊所到社区再返回
- 批准号:
9458547 - 财政年份:2016
- 资助金额:
$ 10.95万 - 项目类别:
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and Back
实施认知筛查和教育支持以改善镰状细胞病青少年和年轻人的预后:从诊所到社区再返回
- 批准号:
10435744 - 财政年份:2016
- 资助金额:
$ 10.95万 - 项目类别:
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and Back
实施认知筛查和教育支持以改善镰状细胞病青少年和年轻人的预后:从诊所到社区再返回
- 批准号:
10198994 - 财政年份:2016
- 资助金额:
$ 10.95万 - 项目类别:
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and Back
实施认知筛查和教育支持以改善镰状细胞病青少年和年轻人的预后:从诊所到社区再返回
- 批准号:
9180330 - 财政年份:2016
- 资助金额:
$ 10.95万 - 项目类别:
SILENT CEREBRAL INFARCT MULTI-CENTER CLINICAL TRIAL
无症状脑梗死多中心临床试验
- 批准号:
7603414 - 财政年份:2007
- 资助金额:
$ 10.95万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 10.95万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 10.95万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 10.95万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 10.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 10.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 10.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 10.95万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 10.95万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 10.95万 - 项目类别: